Shionogi & Co., Ltd. (OTCMKTS:SGIOY) Short Interest Up 329.5% in November

Shionogi & Co., Ltd. (OTCMKTS:SGIOY) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 368,900 shares, an increase of 329.5% from the October 31st total of 85,900 shares. Based on an average daily volume of 503,800 shares, the days-to-cover ratio is presently 0.7 days.

Shionogi & Co., Ltd. Price Performance

Shares of SGIOY traded up $0.02 during trading hours on Wednesday, hitting $6.95. The stock had a trading volume of 165,770 shares, compared to its average volume of 158,057. The company’s fifty day moving average is $7.66 and its two-hundred day moving average is $9.63. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.86 and a quick ratio of 5.37. Shionogi & Co., Ltd. has a 52 week low of $6.22 and a 52 week high of $9.11. The stock has a market capitalization of $12.37 billion, a price-to-earnings ratio of 11.78, a P/E/G ratio of 4.65 and a beta of 0.22.

About Shionogi & Co., Ltd.

Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.